We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-0.24%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.46B
AUM Growth
-$25.5M
Cap. Flow
-$13.6M
Cap. Flow %
-0.93%
Top 10 Hldgs %
23.16%
Holding
4,911
New
1,154
Increased
1,500
Reduced
1,460
Closed
679

Sector Composition

Rank Sector Weight
1 Technology 9.13%
2 Financials 8.46%
3 Industrials 5.89%
4 Healthcare 5.51%
5 Consumer Discretionary 5.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADRE
2801
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$13K ﹤0.01%
345
-227
-40% -$8.85K
MACK
2802
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$13K ﹤0.01%
2,842
-1,348
-32% -$6.74K
ALDX icon
2803
Aldeyra Therapeutics
ALDX
$92.9M
$12K ﹤0.01%
2,293
+2,094
+1,052% +$11.3K
ALKS icon
2804
Alkermes
ALKS
$8.18B
$12K ﹤0.01%
591
+101
+21% +$2.2K
ALV icon
2805
Autoliv
ALV
$8.86B
$12K ﹤0.01%
147
+136
+1,236% +$9.69K
ATEN icon
2806
A10 Networks
ATEN
$2.07B
$12K ﹤0.01%
1,744
-4,272
-71% -$30.7K
AXTI icon
2807
AXT Inc
AXTI
$5.22B
$12K ﹤0.01%
3,442
+2,124
+161% +$8.18K
BATRA icon
2808
Atlanta Braves Holdings Series A
BATRA
$3.42B
$12K ﹤0.01%
435
+262
+151% +$7.41K
BBAR icon
2809
BBVA Argentina
BBAR
$3.44B
$12K ﹤0.01%
+2,700
New +$21K
CCNE icon
2810
CNB Financial Corp
CCNE
$1.02B
$12K ﹤0.01%
+444
New +$12.2K
CHN
2811
DELISTED
China Fund
CHN
$12K ﹤0.01%
+600
New +$11.9K
CIA icon
2812
Citizens
CIA
$196M
$12K ﹤0.01%
+1,746
New +$12.2K
COMT icon
2813
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.22B
$12K ﹤0.01%
373
-885
-70% -$28.1K
CRH icon
2814
CRH
CRH
$66.8B
$12K ﹤0.01%
336
-2,015
-86% -$66.8K
CTMX icon
2815
CytomX Therapeutics
CTMX
$741M
$12K ﹤0.01%
1,654
+780
+89% +$7.69K
DNTH icon
2816
Dianthus Therapeutics
DNTH
$6.11B
$12K ﹤0.01%
76
+68
+850% +$12.9K
EVR icon
2817
Evercore
EVR
$11.7B
$12K ﹤0.01%
152
-22,133
-99% -$1.83M
FFIC
2818
DELISTED
Flushing Financial
FFIC
$12K ﹤0.01%
584
+147
+34% +$3K
FWRD icon
2819
Forward Air
FWRD
$644M
$12K ﹤0.01%
192
-1,037
-84% -$63.5K
HBCP icon
2820
Home Bancorp
HBCP
$557M
$12K ﹤0.01%
+320
New +$12K
HCSG icon
2821
Healthcare Services Group
HCSG
$1.52B
$12K ﹤0.01%
513
-369
-42% -$9.31K
IWN icon
2822
iShares Russell 2000 Value ETF
IWN
$14.5B
$12K ﹤0.01%
100
-58,383
-100% -$6.9M
JILL icon
2823
J. Jill
JILL
$280M
$12K ﹤0.01%
+1,281
New +$13K
KTCC icon
2824
Key Tronic
KTCC
$46.7M
$12K ﹤0.01%
1,900
+911
+92% +$4.81K
LOB icon
2825
Live Oak Bancshares
LOB
$1.95B
$12K ﹤0.01%
687
-1,809
-72% -$32.6K

Similar funds

Tower Research Capital (TRC)'s Q3 2019 Portfolio in Review

As of Q3 2019, Tower Research Capital (TRC) held 4,911 positions worth $1.46B, down 1.7% from $1.48B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC)'s Q3 2019 filing shows 1,154 new, 1,500 increased, 1,460 reduced and 679 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $119M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 4.3% a quarter earlier, followed by Financials and Industrials.

  • Tower Research Capital (TRC)'s largest Q3 2019 buy was iShares Core MSCI EAFE ETF: 142,521 shares worth $8.7M.
  • Tower Research Capital (TRC) added most to State Street Consumer Staples Select Sector SPDR ETF in Q3 2019, an estimated $45.9M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $119M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q3 2019, selling an estimated $26.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $1.46B portfolio in Q3 2019.
  • Tower Research Capital (TRC) opened 1,154 new positions and closed 679 in Q3 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 1.7% quarter-over-quarter to $1.46B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2019, filed 5 Nov 2019.